We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Nitric Oxide Shown To Cause Colon Cancer

By LabMedica International staff writers
Posted on 12 Feb 2009
Scientists have long established a link between inflammation, cancer, and the compound nitric oxide, which may be produced when the immune system responds to bacterial infections, including those of the colon. More...
However, the precise nature of the relationship was unknown--until now.

Researchers from the Massachusetts Institute of Technology's (MIT; Cambridge, MA, USA) division of comparative medicine and department of biological engineering recently discovered that nitric oxide produced by inflammatory cells during bacterial infection can cause colon cells to become cancerous. This finding suggests that suppressing the compound may help prevent or treat colon cancer, the third most common form of cancer in the United States.

The researchers, led by Dr. James Fox, director of the division of comparative medicine, reported their findings in the January 19, 2008, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences (PNAS).

Many years ago, it was discovered that gastrointestinal infection by Helicobacter pylori is frequently associated with cancer in humans; a related bacteria called H. hepaticus has similar effects in mice. Nitric oxide is produced during the inflammatory response to such bacterial infection, but it has been unclear whether it was damaging cells or protecting them. By studying the mice, the MIT team revealed that nitric oxide produced by different types of cells has different effects. "Nitric oxide delivered by inflammatory cells, in particular, is important in causing changes in intestinal epithelial cells, setting the stage for cancer development,” said Dr. Susan Erdman, lead research scientist in the division of comparative medicine and lead author of the PNAS article.

In mice infected with H. hepaticus, the researchers found that blocking an enzyme required to generate nitric oxide reduced colon cancer rates. More research is needed to study the exact effects of nitric oxide and develop potential clinical therapies for colon cancer, according to Dr. Erdman. "Therapies will need to be targeted to inhibit the damaging effects of nitric oxide while preserving as many of the protective elements of nitric oxide as possible,” she said.

"This study is a wonderful example of the value and final product that results from an interdisciplinary team effort,” concluded Dr. Fox.

Related Links:

Massachusetts Institute of Technology



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Manual Pipetting Aid
Pipette Controllers macro
Prefilled Tubes
Prefilled 5.0ml Tubes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image: At the MHH Institute of Human Genetics: Prof. Dr. Doris Steinemann, Dr. Bernardus Aldrige Allister and Prof. Dr Monika Golas (from left). (Image Credit: Karin Kaiser/MHH)

Multi-Omics Analysis Identifies Additional Risk Genes in Hereditary Breast and Ovarian Cancer

Hereditary breast and ovarian cancer can be difficult to explain genetically, leaving many high-risk families without clear answers. Although 13 established risk genes, including BRCA1 and BRCA2, are routinely... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.